Purchase Order 75N91023P00751
Award Date
9/1/23
Potential Completion Date
2/29/24
Potential Value
$22K
Federal Agency
National Cancer Institute
Ultimate Awardee
Not listed
NAICS Category
541715 - Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
PSC Category
Q301 - Reference Laboratory Testing
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Italy
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the National Cancer Institute, a civilian agency, to Istituto Oncologico Veneto in Italy. The $99,150.00 Firm Fixed Price contract is for the review of tumor, adjacent normal, and nevus remnant samples, as well as DNA extraction from melanoma and other skin lesions collected from Mediterranean populations. The contract does not have a set-aside designation. No subcontractors are mentioned. The contract supports the National Cancer Institute's research and...
This is a firm fixed-price purchase order contract awarded by the National Cancer Institute (NCI), a civilian agency within the U.S. Department of Health and Human Services, to Istituto Superiore DI Sanita' - ISS, a foreign government entity in Italy. The contract, valued at $79,994.00, is for extending code and methods to provide estimates by phases of care (MIAMOD/PIAMOD). The contract does not have a set-aside designation and the ultimate completion date is February 28, 2018. ISS has...
This is a Delivery Order contract awarded by the National Cancer Institute (NCI), a civilian agency, to Melanoma Institute Australia, a foreign-owned non-profit organization. The contract is for $192,500.00 and is related to the NCI Cancer Genome Atlas Program, which involves the collection of tissue samples and data from various types of cancer. There is no set-aside designation for this contract. The contract is a Firm Fixed Price type and has an ultimate completion date of September 30, 2014....
Universita' Degli Studi DI Cagliari (the University) has been awarded a firm fixed price purchase order contract from the National Institute on Aging (NIA), a component of the National Institutes of Health (NIH) within the Department of Health and Human Services (HHS), to provide laboratory testing services. The contract has a potential value of $22,000 and a completion date of December 6, 2023. The University will conduct research evaluating drug compounds for Parkinson's disease in animal...
The National Cancer Institute (NCI) awarded a $142,009.29 firm fixed-price purchase order contract to Fundacio Centre De Regulacio Genomica, a non-profit biomedical research institute, to perform targeted gene sequencing on samples collected by NCI's Division of Cancer Epidemiology and Genetics. This contract, which does not have a set-aside designation, is expected to be completed by June 2023. The contract was awarded in September 2021 under simplified acquisition procedures for commercial...
The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a $1,498,500.00 firm fixed price delivery order contract to The Johns Hopkins University on August 30, 2023 for the upgrade of whole genome sequencing on 2,294 experimental DNA samples. The contract has a completion date of December 31, 2025 and is not set aside for any specific business type. The Johns Hopkins University, a private non-profit research university, will provide the required...
<p>The U.S. National Cancer Institute awarded a $395,448.37 firm fixed-price purchase order contract to Menarini Silicon Biosystems, Inc. for the procurement of one single cell isolation DEPArray system with 1-year dedicated, on-site field application support. The contract does not have a set-aside designation. The award is not associated with a larger contract vehicle. The contract was awarded on July 1, 2015 and has an ultimate completion date of April 18, 2020.</p>
This is a $500,000.00 firm fixed price delivery order contract awarded by the National Cancer Institute (NCI), a component of the National Institutes of Health (NIH), to The Johns Hopkins University. The contract is to collect whole genome sequence data to enhance the value of the first multi-center study of colorectal cancer risk factors and biology in Nigeria. The contract has an ultimate completion date of December 31, 2025 and does not have a set-aside designation. The Johns Hopkins...
This is a $11,408,934.00 Cost No Fee definitive contract awarded by the National Institute on Aging, a civilian agency, to Consiglio Nazionale Delle Ricerche - Istituto DI Ricerca Genetica E Biomedica in Italy. The contract is for the "GENETIC AND EPIDEMIOLOGICAL FACTORS FOR AGE-RELATED TRAITS AND DISEASES IN THE SARDINIAN POPULATION (SARDINIA5)" and has a period of performance from June 1, 2021 to May 31, 2026. The contract was not set aside for any special designation. The awardee,...
This is a $414,000.00 firm fixed price delivery order awarded by the National Institutes of Health (NIH) National Human Genome Research Institute to The Johns Hopkins University, a private non-profit educational institution. The order is for custom targeted sequencing of 50 genes (0.5-1MB) for the National Cancer Institute (NCI) and has a completion date of September 30, 2023. The contract does not have a set-aside designation. The Johns Hopkins University is a leading provider of biomedical...